Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A prospective, randomized, placebo-controlled, double-blinded, phase III clinical trial of the therapeutic use of convalescent plasma in the treatment of patients with moderate to severe COVID-19
Epistemonikos ID: d460139b38c4d3980c18ff498570bc72c064a4d8
First added on: Aug 19, 2020